Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. CDC Says 182,387,840 Individuals Have Been Fully Vaccinated Against Covid-19 As Of Sept 22

09/22/2021 | 05:09pm EDT

Sept 22 (Reuters) - U.S. CDC :

* U.S. CDC SAYS DELIVERED 468,248,675 DOSES OF COVID-19 VACCINE AS OF SEPT 22 VERSUS 467,249,715 DOSES DELIVERED AS OF SEPT 21

* U.S. CDC SAYS ADMINISTERED 387,493,716 DOSES OF COVID-19 VACCINE AS OF SEPT 22 VERSUS 386,780,816 DOSES ADMINISTERED AS OF SEPT 21

* U.S. CDC SAYS 2.30 MILLION PEOPLE RECEIVED AN ADDITIONAL COVID-19 VACCINE DOSE SINCE AUGUST 13, 2021

* U.S. CDC SAYS 212,545,360 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF SEPT 22 VERSUS 212,255,202 INDIVIDUALS AS OF SEPT 21

* U.S. CDC SAYS 182,387,840 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF SEPT 22 VERSUS 182,012,343 INDIVIDUALS AS OF SEPT 21


ę Reuters 2021
All news about MODERNA, INC.
05:22pStocks rise on strong earnings reports
RE
04:46pMODERNA : Wall St ends up with Goldman; Dow posts biggest weekly rise since June
RE
03:42pJOHNSON & JOHNSON : COVID-19 Vaccine Booster Shot Receives FDA Advisory Panel Recommendati..
MT
03:42pMODERNA : NIH's Collins Says FDA Wants to Study Moderna Covid Shot in Kids Longer
MT
03:02pMODERNA : U.S. administers 406.6 mln doses of COVID-19 vaccines - CDC
RE
02:55pFDA panel recommends J&J COVID-19 booster for all recipients who got first shot
AQ
02:44pMODERNA : Wall St climbs after week of strong bank results; market set for weekly gains
RE
02:13pMODERNA : COVID SCIENCE-Statins may slightly lower COVID-19 death risk; using a different ..
RE
01:40pPFIZER : FDA panel endorses booster shot for J&J COVID-19 vaccine
AQ
01:35pEquities Climb Midday With Yields After Surprise Retail Sales Gain
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 335 M - -
Net income 2021 12 514 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 10,9x
Yield 2021 -
Capitalization 134 B 134 B -
EV / Sales 2021 5,95x
EV / Sales 2022 5,22x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 324,21 $
Average target price 299,31 $
Spread / Average Target -7,68%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.210.34%133 962
LONZA GROUP AG26.44%57 839
IQVIA HOLDINGS INC.38.89%47 294
SEAGEN INC.-1.38%30 963
CELLTRION, INC.-38.72%25 574
ALNYLAM PHARMACEUTICALS, INC.60.47%24 874